Hims & Hers Health, Inc.
Hims & Hers is a direct-to-consumer telehealth and prescription platform whose growth hinges on telehealth deregulation, online prescribing rules, and compounded-drug policy.
BusinessWhat HIMS does
Hims & Hers operates a subscription-based telehealth platform selling prescription and OTC treatments for sexual health, hair loss, weight loss (including GLP-1s), mental health, and dermatology. Revenue is primarily recurring consumer subscriptions plus affiliated pharmacy fulfillment.
Executive Branch ConflictsHIMS held by Trump-administration officials
Lifetime Government AwardsHIMS federal contracts
HIMS doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding HIMS
Politicians Trading HIMSMembers of Congress with recent HIMS positions
Congressional TradesWho in Congress is trading HIMS
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills Affecting HIMSLive legislation impacting this stock
Political ProfileWhere HIMS sits in Washington
bipartisan
HIMS reacts sharply to FDA/DEA actions on compounded GLP-1s and telehealth prescribing rules, though many moves are company-specific news rather than broad legislation.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA/FTC scrutiny of compounded GLP-1 marketing
- DEA telehealth prescribing restrictions
- state medical board telehealth licensing rules
- FTC advertising and subscription-cancellation enforcement
Regulatory opportunities
- permanent Medicare telehealth flexibility
- removal of in-person prescribing requirements
- price-transparency and cash-price disclosure rules (HR.4822)
- expanded coverage of virtual mental health
LobbyingWho's hired to advocate for HIMS
Live signals + predictions for HIMS — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades HIMS
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord